Associations between human liver and kidney cadmium content and immunochemically detected CYP4A11 apoprotein
- 24 December 2001
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 63 (4) , 693-696
- https://doi.org/10.1016/s0006-2952(01)00905-4
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Cadmium Levels in the Lung, Liver, Kidney Cortex, and Urine Samples from Australians without Occupational Exposure to MetalsArchives of environmental health, 2002
- Relationships between non-occupational cadmium exposure and expression of nine cytochrome P450 forms in human liver and kidney cortex samplesBiochemical Pharmacology, 2001
- Safe levels of cadmium intake to prevent renal toxicity in human subjectsBritish Journal of Nutrition, 2000
- Formation of 20-Hydroxyeicosatetraenoic Acid, a Vasoactive and Natriuretic Eicosanoid, in Human KidneyJournal of Biological Chemistry, 2000
- Development of a Comprehensive Panel of Antibodies against the Major Xenobiotic Metabolising Forms of Cytochrome P450 in HumansBiochemical Pharmacology, 1998
- Molecular Genetics of Human Blood Pressure VariationScience, 1996
- Influence of clinicopathological variables on CYP protein expression in human liverJournal of Gastroenterology and Hepatology, 1996
- Effect of several metallothionein inducers on oxidative stress defense mechanisms in ratsToxicology, 1995